Brief: BioScrip And Option Care To Merge

Option Care Health

15/03/2019 11:42

March 15 (Reuters) - BioScrip Inc  BIOS.O :
    * PRESS RELEASE - HOME AND ALTERNATE SITE INFUSION THERAPY
PROVIDERS BIOSCRIP AND OPTION CARE TO MERGE
    * BIOSCRIP INC - BIOSCRIP TO ISSUE NEW SHARES TO OPTION
CARE'S
SHAREHOLDER, WHICH WILL OWN APPROXIMATELY 80% OF COMBINED
COMPANY ON FULLY DILUTED BASIS
    * BIOSCRIP INC - COMBINED COMPANY'S COMMON STOCK WILL
CONTINUE TO
BE LISTED ON NASDAQ GLOBAL MARKET
    * BIOSCRIP INC - TRANSACTION HAS BEEN UNANIMOUSLY APPROVED
BY
BOARDS OF DIRECTORS OF BOTH BIOSCRIP AND OPTION CARE
    * BIOSCRIP INC - COMBINED CO WILL BE LED BY OPTION CARE
CHIEF
EXECUTIVE OFFICER JOHN RADEMACHER AND OPTION CARE CHIEF
FINANCIAL OFFICER MIKE SHAPIRO
    * BIOSCRIP INC - CO'S PRESIDENT AND CEO DANIEL E. GREENLEAF
WILL
REMAIN ACTIVE IN COMBINED CO AS A SPECIAL ADVISOR TO ITS BOARD
OF DIRECTORS
    * BIOSCRIP - CO,OPTION CARE SECURED COMMITTED FINANCING FROM
BANK
OF AMERICA MERRILL LYNCH, FUNDS AFFILIATED WITH ARES MANAGEMENT,
GOLDMAN SACHS MERCHANT BANKING DIVISION
    * BIOSCRIP - CO,OPTION CARE SECURED COMMITTED FINANCING TO
REFINANCE & SIMPLIFY COMBINED CO'S CAPITAL STRUCTURE
    * BIOSCRIP - CO TO ISSUE NEW SHARES TO OPTION CARE'S
SHAREHOLDER,
OWNED BY INVESTMENT FUNDS RELATED TO MADISON DEARBORN PARTNERS,
& WALGREENS BOOTS ALLIANCE

Source text for Eikon:  ID:nGNX2xlhl2 
Further company coverage:  BIOS.O 

 ((Reuters.Briefs@thomsonreuters.com;))